Laura A. Williams - Jun 15, 2022 Form 3 Insider Report for ARDELYX, INC. (ARDX)

Role
Chief Medical Officer
Signature
/s/ Elizabeth Grammer, Attorney-in-Fact for Laura A. Williams
Stock symbol
ARDX
Transactions as of
Jun 15, 2022
Transactions value $
$0
Form type
3
Date filed
6/23/2022, 06:49 PM
Previous filing
Jun 3, 2022
Next filing
Aug 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ARDX Common Stock 244K Jun 15, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ARDX Stock Option (Right to Buy) Jun 15, 2022 Common Stock 105K $5.19 Direct F2
holding ARDX Stock Option (Right to Buy) Jun 15, 2022 Common Stock 192K $0.99 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 49,582 Restricted stock units.
F2 Twenty Five Percent (25%) of the shares subject to the option vest on November 2, 2021 and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
F3 The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.